Propanoic acid derivatives
AssigneeCelltech Therapeutics Limited
InventorsRikki Peter Alexander, Barry John Langham, James Thomas Reuberson, Emma Louise Trown, Graham John Warrellow
Life of this patent
Estimating the term…
Loading patent…
AssigneeCelltech Therapeutics Limited
InventorsRikki Peter Alexander, Barry John Langham, James Thomas Reuberson, Emma Louise Trown, Graham John Warrellow
Estimating the term…
Propanoic acid derivatives of formula (1) are described: Ar—X1—Ar1—Z—R (1) in which Ar is a nitrogen base containing group; X1 is linker atom or group; Ar1 is an optionally substituted 5- or 6-membered nitrogen-containing aromatic or non-aromatic monocycle; Z is a group —CH(R13)CH2— [in which R13 is an optionally substituted aliphatic, cycloaliphatic, heteroaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group], —C(R12a)(R13)—CH(R12b)— [in which R12a and R12b together with the carbon atoms to which they are attached form a C3-7cycloalkyl group] or C(R13)═CH—; R is a carboxylic acid (—CO2H) or a derivative or biostere thereof; and the salts, solvates, hydrates and N-oxides thereof. The compounds are able to inhibit the binding of αV integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
A compound of formula (1):
A compound which is:
Dependencies are inferred from the claim text.